Skip to content
Research Article Open access CC BY 4.0

Isolation and Antibiotic Resistance of Achromobacter xylosoxidans from Non-respiratory Tract Clinical Samples: A 10-year Retrospective Study in a Tertiary-care Hospital in Hungary

Márió Gajdács

Journal of Pharmaceutical Research International · pp. 1–7 · Published 5 Feb 2020

10.9734/jpri/2020/v32i130387

Abstract

Aims: To assess the prevalence of A. xylosoxidans isolated from non-respiratory tract samples from adult inpatients and outpatients and the antibiotic resistance levels at a tertiary-care teaching hospital in Szeged, Hungary retrospectively, during a 10-year study period. Study Design: Retrospective microbiological study. Place and Duration of Study: 1st of January 2008 - 31st of December 2017 at the University of Szeged, which is affiliated with the Albert Szent-Györgyi Clinical Center, a primary- and tertiary-care teaching hospital in the Southern Great Plain of Hungary. Methodology: Data collection was performed electronically. Antimicrobial susceptibility testing (AST) was performed using disk diffusion method and when appropriate, E-tests on Mueller–Hinton agar plates. Results: During the 10-year study period, a total of 68 individual A. xylosoxidans isolates were identified (6.8±3.6/year, range: 0-11 isolates). The frequency of isolation in the first half of the study period (2008-2017) was n=22, while in 2013-2017, this number was n=46. The majority of isolates (51 out of 68) were from inpatient departments. 32 out of 68 patients were female (female-to-male ratio: 0.89). The susceptibilities of the respective A. xylosoxidans isolates (n=68) were the following: high levels of susceptibility for imipenem and meropenem (n=63; 92.6%), and moxifloxacin (n=55; 80.9%), while higher rates of resistance were detected for sulfamethoxazole/trimethoprim (susceptible: n=36; 52.9%), ciprofloxacin (susceptible: n=40; 58.8%) and almost all isolates were resistant to ceftazidime (susceptible: n=3; 4.4%) and cefepime (n=2; 2.9%). Conclusion: The existing literature on Achromobacter infections in the context of non-respiratory human infections is scarce, as the incidence of these pathogens in clinically-relevant syndromes in low. The developments in diagnostic technologies in routine clinical microbiology will probably lead to a shift in the isolation frequency of these bacteria in the future.

Achromobacter xylosoxidans non-fermenting Gram-negative epidemiology immunocompromised retrospective clinical microbiology medicine.

References (28)

  1. 1 EUCAST expert rules in antimicrobial susceptibility testing [DOI]
  2. 2 Achromobacter xylosoxidans in cystic fibrosis: Prevalence and clinical relevance [DOI]
  3. 3 Prevalence and Outcomes of Achromobacter Species Infections in Adults with Cystic Fibrosis: a North American Cohort Study [DOI]
  4. 4 Resistance Trends and Epidemiology of Citrobacter-Enterobacter-Serratia in Urinary Tract Infections of Inpatients and Outpatients (RECESUTI): A 10-Year Survey [DOI]
  5. 5 Resistance Levels and Epidemiology of Non-Fermenting Gram-Negative Bacteria in Urinary Tract Infections of Inpatients and Outpatients (RENFUTI): A 10-Year Epidemiological Snapshot [DOI]
  6. 6 Predictors of pulmonary exacerbations in patients with cystic fibrosis infected with multi-resistant bacteria [DOI]
  7. 7 Epidemiology and resistance of Achromobacter xylosoxidans from cystic fibrosis patients in Dijon, Burgundy: First French data [DOI]
  8. 8 Marked increase in incidence of Achromobacter xylosoxidans infections caused by sporadic acquisition from the environment [DOI]
  9. 9 Achromobacter animicus sp. nov., Achromobacter mucicolens sp. nov., Achromobacter pulmonis sp. nov. and Achromobacter spiritinus sp. nov., from human clinical samples [DOI]
  10. 10 Achromobacter xylosoxidans bacteremia: clinical and microbiological features in a 10-year case series.
  11. 11 Achromobacter xylosoxidans, an emerging pathogen in catheter-related infection in dialysis population causing prosthetic valve endocarditis: a case report and review of literature [DOI]
  12. 12 Epidemic Achromobacter xylosoxidans strain among Belgian cystic fibrosis patients and review of literature [DOI]
  13. 13 Uncovering Differences in Virulence Markers Associated with Achromobacter Species of CF and Non-CF Origin [DOI]
  14. 14 Genotypic and Phenotypic Applications for the Differentiation and Species-Level Identification of Achromobacter for Clinical Diagnoses [DOI]
  15. 15 Identification of Achromobacter xylosoxidans by detection of the blaOXA-114-like gene intrinsic in this species [DOI]
  16. 16 Recurrent Achromobacter xylosoxidans Bacteremia Associated with Persistent Lymph Node Infection in a Patient with Hyper-Immunoglobulin M Syndrome [DOI]
  17. 17 Colonization by Alcaligenes xylosoxidans in Children with Cystic Fibrosis: A Retrospective Clinical Study Conducted by Means of Molecular Epidemiological Investigation [DOI]
  18. 18 Achromobacter xylosoxidans Infection Presenting as a Pulmonary Nodule Mimicking Cancer [DOI]
  19. 19 Epidemiology and antibiotic resistance trends of Pantoea species in a tertiary-care teaching hospital: A 12-year retrospective study [DOI]
  20. 20 Biofilm formation of Achromobacter xylosoxidans on contact lens [DOI]
  21. 21 Achromobacter xylosoxidans meningitis in an immunosuppressed patient [DOI]
  22. 22 Nosocomial Achromobacter xylosoxidans Infections [DOI]
  23. 23 A novel bacterium Achromobacter xylosoxidans as a cause of liver abscess: Three case reports [DOI]
  24. 24 Achromobacter, Alcaligenes and Related Genera [DOI]
  25. 25 Evaluation of colistin susceptibility in multidrug-resistant clinical isolates from cystic fibrosis, France [DOI]
  26. 26 Osteomyelitis caused by Achromobacter xylosoxidans [DOI]
  27. 27 Complicated septic shock caused by Achromobacter xylosoxidans bacteremia in a patient with acute lymphoblastic leukaemia [DOI]
  28. 28 [Alcaligenes xylosoxidans--a pathogen of chronic ear infection].

Cited by 0

No indexed citations yet.

Related research

Article metrics

Real usage data collected on this platform.

8

Page views

0

PDF downloads

1

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.